Oliveira, Cláudia Di Lorenzo
https://orcid.org/0000-0001-8533-8155
Mayo Clinic
Universidade de São Paulo
Citations 1
P1 Phase 3 ESSENCE trial evaluating semaglutide in metabolic dysfunction-associated steatohepatitis (MASH): part 1 results and secondary analysis
Kliers, Iris, Østergaard, Laura, Kjær, Mette Skalshøi , Calì, Anna, Engebresten, Kristiane, Oliveira, Cláudia Di Lorenzo , Shoeb, A.K. Mohammed, Petta, Salvatore, Rinella, Mary E., Newsome, Philip N. , Sanyal, Arun J. , Long, Michelle T. , Abdelmalek, Manal F. , Bugianesi, Elisabetta , Castera, Laurent , George, Jacob , Chan, Wah‐Kheong , Papatheodoridis, George , Petta, Salvatore, Roden, Michael , Yılmaz, Yusuf , Ratziu, Vlad
P1 Phase 3 ESSENCE trial evaluating semaglutide in metabolic dysfunction-associated steatohepatitis (MASH): part 1 results and s | October 8, 2025 | Volume: No volume available | Issue: No issue available | Pages: A15.1-A15
